IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm

References

• Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112. doi:10.1159/000346087
   PubMed Web of Science ®Google Scholar
• Signorelli F, Turjman F, Gory B, Labeyrie PE, Pelissou-Guyotat I, Riva R. Hemodynamics, inflammation, vascular remodeling, and the development and rupture of intracranial aneurysms: a review. Neuroimmunol Neuroinflamm. 2015;2(2):59. doi:10.4103/2347-8659.154885
   Google Scholar
• Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28(4):372–380. doi:10.1179/016164106X14973
   PubMed Web of Science ®Google Scholar
• Chalouhi N, Ali MS, Jabbour PM, et al. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 2012;32(9):1659–1676. doi:10.1038/jcbfm.2012.84
   PubMed Web of Science ®Google Scholar
• Chalouhi N, Ali MS, Starke RM, et al. Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2012;2012:1–12. doi:10.1155/2012/271582
   Web of Science ®Google Scholar
• Zhang HF, Zhao MG, Liang GB, Song ZQ, Li ZQ. Expression of pro-inflammatory cytokines and the risk of intracranial aneurysm. Inflammation. 2013;36(6):1195–1200. doi:10.1007/s10753-013-9655-6
   PubMed Web of Science ®Google Scholar
• Sawyer DM, Amenta PS, Medel R, Dumont AS. Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research. Mediators Inflamm. 2015;2015:1–10. doi:10.1155/2015/896283
   Web of Science ®Google Scholar
• Signorelli F, Sela S, Gesualdo L, et al. Hemodynamic stress, inflammation, and intracranial aneurysm development and rupture: a systematic review. World Neurosurg. 2018;115:234–244. doi:10.1016/j.wneu.2018.04.143
   PubMed Web of Science ®Google Scholar
• Labeyrie P-E, Goulay R, Martinez de Lizarrondo S, et al. Vascular tissue-type plasminogen activator promotes intracranial aneurysm formation. Stroke. 2017;48(9):2574–2582. doi:10.1161/STROKEAHA.117.017305
   PubMed Web of Science ®Google Scholar
• Signorelli F, Pailler-Mattei C, Gory B, et al. Biomechanical characterization of intracranial aneurysm wall: a multiscale study. World Neurosurg. 2018;119:e882–e889. doi:10.1016/j.wneu.2018.07.290
   PubMed Web of Science ®Google Scholar
• Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett. 2004;25(1–2):141–147.
   PubMed Web of Science ®Google Scholar
• Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery. 1999;45(5):1137–1147. doi:10.1097/00006123-199911000-00024
   PubMed Web of Science ®Google Scholar
• Aoki T, Nishimura M. Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapy. Expert Opin Ther Targets. 2010;14(3):265–273. doi:10.1517/14728221003586836
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. doi:10.1101/cshperspect.a016295
   PubMed Web of Science ®Google Scholar
• Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi:10.1016/s0065-2776(08)60532-5
   PubMed Web of Science ®Google Scholar
• Osuka K, Suzuki Y, Tanazawa T, et al. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir. 1998;140(9):943–951. doi:10.1007/s007010050197
   PubMed Web of Science ®Google Scholar
• Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70(4):534–537. doi:10.1136/jnnp.70.4.534
   PubMed Web of Science ®Google Scholar
• Ďuriš K, Neuman E, Vybíhal V, et al. Early dynamics of interleukin-6 in cerebrospinal fluid after aneurysmal Subarachnoid hemorrhage. J Neurol Surg Part a Cent Eur Neurosurg. 2018;79(2):145–151. doi:10.1055/s-0037-1604084
   PubMedGoogle Scholar
• Ni W, Gu YX, Song DL, Leng B, Li PL, Mao Y. The relationship between IL-6 in CSF and occurrence of vasospasm after subarachnoid hemorrhage. In: Early Brain Injury or Cerebral Vasospasm. Vienna: Springer;2011:203–208. doi:10.1007/978-3-7091-0353-1_35
   Google Scholar
• Kao HW, Lee KW, Kuo CL, et al. Interleukin-6 as a prognostic biomarker in ruptured intracranial aneurysms. PLoS One. 2015;10(7):6–13. doi:10.1371/journal.pone.0132115
   Web of Science ®Google Scholar
• Kamińska J, Lyson T, Chrzanowski R, et al. Ratio of IL-8 in CSF versus serum is elevated in patients with unruptured brain aneurysm. J Clin Med. 2020;9(6):1761. doi:10.3390/jcm9061761
   PubMed Web of Science ®Google Scholar
• Murayama Y, Takao H, Ishibashi T, et al. Risk analysis of unruptured intracranial aneurysms: prospective 10-year cohort study. Stroke. 2016;47(2):365–371. doi:10.1161/STROKEAHA.115.010698
   PubMed Web of Science ®Google Scholar
• Reiber H. Knowledge-base for interpretation of cerebrospinal fluid data patterns. Essentials in neurology and psychiatry. Arq Neuropsiquiatr. 2016;74(6):501–512. doi:10.1590/0004-282x20160066
   PubMed Web of Science ®Google Scholar
• Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw. 2017;71(1):551–563. doi:10.5604/01.3001.0010.3836
   Google Scholar
• Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184(2):101–122. doi:10.1016/S0022-510X(00)00501-3
   PubMed Web of Science ®Google Scholar
• Lindblad C, Nelson DW, Zeiler FA, et al. Influence of blood-brain barrier integrity on brain protein biomarker clearance in severe traumatic brain injury: a longitudinal prospective study. J Neurotrauma. 2020;37(12):1381–1391. doi:10.1089/neu.2019.6741
   PubMed Web of Science ®Google Scholar
• Dimopoulou I, Korfias S, Dafni U, et al. Protein S-100b serum levels in trauma-induced brain death. Neurology. 2003;60(6):947–951. doi:10.1212/01.WNL.0000049931.77887.7F
   PubMed Web of Science ®Google Scholar
• Aloisi F, Carè A, Borsellino G, et al. Production of hemolymphopoietic cytokines normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol. 1992;149(7):2358–2366.
   PubMed Web of Science ®Google Scholar
• Romano M, Sironi M, Toniatti C, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997;6(3):315–325. doi:10.1016/S1074-7613(00)80334-9
   PubMed Web of Science ®Google Scholar
• Biswas P, Delfanti F, Bernasconi S, et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 1998;91(1):258–265. doi:10.1182/blood.V91.1.258
   PubMed Web of Science ®Google Scholar
• Chalouhi N, Points L, Pierce GL, Ballas Z, Jabbour P, Hasan D. Localized increase of chemokines in the lumen of human cerebral aneurysms. Stroke. 2013;44(9):2594–2597. doi:10.1161/STROKEAHA.113.002361
   PubMed Web of Science ®Google Scholar
• Morgan L, Cooper J, Montgomery H, Kitchen N, Humphries SE. The interleukin-6 gene −174G>C and −572G>C promoter polymorphisms are related to cerebral aneurysms. J Neurol Neurosurg Psychiatry. 2006;77(8):915–917. doi:10.1136/jnnp.2005.081976
   PubMed Web of Science ®Google Scholar
• Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease. J Hypertens. 2003;21(10):1787–1803. doi:10.1097/00004872-200310000-00002
   PubMed Web of Science ®Google Scholar
• Tylicka M, Matuszczak E, Kamińska J, et al. Intraoperative peritoneal interleukin-6 concentration changes in relation to the high-mobility group protein B1 and heat shock protein 70 levels in children undergoing cholecystectomy. Mediators Inflamm. 2020;2020:1–9. doi:10.1155/2020/9613105
   Web of Science ®Google Scholar
• Tada Y, Yagi K, Kitazato KT, et al. Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats. J Hypertens. 2010;28(9):1883–1891. doi:10.1097/HJH;0b013e32833c2273
   PubMed Web of Science ®Google Scholar
• Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell. 2000;11(12):4131–4142. doi:10.1091/mbc.11.12.4131
   PubMed Web of Science ®Google Scholar
• Schulzke JD, Gitter AH, Mankertz J, et al. Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta Biomembr. 2005;1669(1):34–42. doi:10.1016/j.bbamem.2005.01.008
   PubMed Web of Science ®Google Scholar
• Yardan T, Erenler AK, Baydin A, Aydin K, Cokluk C. Usefulness of S100B protein in neurological disorders. J Pak Med Assoc. 2011;61(3):276–281.
   PubMed Web of Science ®Google Scholar
• Rezaei O, Pakdaman H, Gharehgozli K, et al. S100 B: a new concept in neurocritical care. Iran J Neurol. 2017;16(2):83–89.
   PubMedGoogle Scholar
• Weiss N, Sanchez-Peña P, Roche S, et al. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology. 2006;104(4):658–666. doi:10.1097/00000542-200604000-00008
   PubMed Web of Science ®Google Scholar